AdAlta Ltd. (AU:1AD) has released an update.
AdAlta Limited has announced an extension of its repayment date for the Treasury Corporation of Victoria loan, now scheduled for October 2024, to coincide with the expected Research and Development Tax Incentive rebate. This strategic move allows the company to maintain working capital for growth initiatives without financial strain. AdAlta, a clinical-stage biotech firm, utilizes its proprietary i-body technology platform to develop novel therapeutics targeting challenging medical conditions.
For further insights into AU:1AD stock, check out TipRanks’ Stock Analysis page.
